207 Mapping Cellular Origins and Developmental Trajectories of Pituitary Neuroendocrine Tumors

INTRODUCTION: The cellular origins of pituitary neuroendocrine tumors (PitNETs) are uncertain, positing that PitNETs may originate from differentiated neuroendocrine cells or adult pituitary stem cells. Understanding these origins is essential for developing targeted therapies aimed at tumor-initiating cells, thereby enhancing treatment efficacy. METHODS: We conducted single-nucleus sequencing on approximately half a million cells, creating the largest database to date. This included samples from two non-tumor postmortem adult pituitaries and 11 resected PitNETs, covering somatotrophic, hormonally active and silent corticotrophic (SCAs), lactotrophic, silent gonadotroph (SGA), and null cell (NCA) adenomas. RESULTS: We reconstructed a single-nuclei atlas of the normal adult human pituitary gland, identifying pituitary stem cells expressing previously known and novel transcription factors. Integrating stem and neuroendocrine nuclei (corticotroph, gonadotroph, lactotroph, thyrotroph, and somatotroph) from normal controls with tumor samples traced the development of PitNET subtypes, with copy number variation (CNV) analysis used to assess chromosomal instability. While most PitNET subtypes derived from their differentiated normal counterpart cells (SGAs from gonadotroph cells, prolactinomas from lactotroph cells, SCA/secreting corticotrophic adenomas from corticotroph cells) and had significant CNV changes, somatotroph and null cell adenomas had minimal CNV changes and arose from pituitary stem cells. While secreting corticotrophic adenomas and SCAs originated from mature corticotroph cells, secreting corticotrophic adenomas appeared earlier in developmental trajectory, representing a less mature state than SCAs. On gene expression analysis, secreting corticotrophic tumors upregulated genes associated with cell morphogenesis and development, suggesting a non-terminal transitional state. Lastly, we characterized key pseudotime genes for each tumor subtype. CONCLUSIONS: This study provides detailed insight into the cellular origins and developmental pathways of various PitNET subtypes, revealing that both stem and differentiated cells can contribute to tumorigenesis in a subtype-specific manner.

Authors

Publication Details

Journal
Neurosurgery
Published
2025-03-14
DOI
https://doi.org/10.1227/neu.0000000000003360_207
Primary Topic
Pituitary Gland Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

207 Mapping Cellular Origins and Developmental Trajectories of Pituitary Neuroendocrine Tumors

Lea T. Grinberg, Jangham Jung, Petros Giannikopoulos, Meeki Lad et al.
Neurosurgery
Pituitary Gland Disorders and Treatments
article

207 Mapping Cellular Origins and Developmental Trajectories of Pituitary Neuroendocrine Tumors

Lea T. Grinberg, Jangham Jung, Petros Giannikopoulos, Meeki Lad, Manish K. Aghi, Robert C. Osorio, Atul Saha, Bruce Miller, William W. Seeley, Nikita Choudhary, Jun Yeop Oh, Alexander J. Ehrenberg, Aaron A. Diaz
article en

Abstract

INTRODUCTION: The cellular origins of pituitary neuroendocrine tumors (PitNETs) are uncertain, positing that PitNETs may originate from differentiated neuroendocrine cells or adult pituitary stem cells. Understanding these origins is essential for developing targeted therapies aimed at tumor-initiating cells, thereby enhancing treatment efficacy. METHODS: We conducted single-nucleus sequencing on approximately half a million cells, creating the largest database to date. This included samples from two non-tumor postmortem adult pituitaries and 11 resected PitNETs, covering somatotrophic, hormonally active and silent corticotrophic (SCAs), lactotrophic, silent gonadotroph (SGA), and null cell (NCA) adenomas. RESULTS: We reconstructed a single-nuclei atlas of the normal adult human pituitary gland, identifying pituitary stem cells expressing previously known and novel transcription factors. Integrating stem and neuroendocrine nuclei (corticotroph, gonadotroph, lactotroph, thyrotroph, and somatotroph) from normal controls with tumor samples traced the development of PitNET subtypes, with copy number variation (CNV) analysis used to assess chromosomal instability. While most PitNET subtypes derived from their differentiated normal counterpart cells (SGAs from gonadotroph cells, prolactinomas from lactotroph cells, SCA/secreting corticotrophic adenomas from corticotroph cells) and had significant CNV changes, somatotroph and null cell adenomas had minimal CNV changes and arose from pituitary stem cells. While secreting corticotrophic adenomas and SCAs originated from mature corticotroph cells, secreting corticotrophic adenomas appeared earlier in developmental trajectory, representing a less mature state than SCAs. On gene expression analysis, secreting corticotrophic tumors upregulated genes associated with cell morphogenesis and development, suggesting a non-terminal transitional state. Lastly, we characterized key pseudotime genes for each tumor subtype. CONCLUSIONS: This study provides detailed insight into the cellular origins and developmental pathways of various PitNET subtypes, revealing that both stem and differentiated cells can contribute to tumorigenesis in a subtype-specific manner.

NeurosurgeryVol. 71(Supplement_1)
Openalex Percentile: Top 93%
Pituitary Gland Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.